TY - JOUR ID - 10442/18147 A1 - Ntouros, P. A. A1 - A1 - Vlachogiannis, N. I. A1 - A1 - Pappa, M. A1 - A1 - Nezos, A. A1 - A1 - Mavragani, C. P. A1 - A1 - Tektonidou, M. G. A1 - A1 - Souliotis, V. L. A1 - A1 - Sfikakis, P. P. Y1 - 2021/// T1 - Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus JF - Clinical immunology (Orlando, Fla.) VL - 229 SN - 15216616 U3 - 10.1016/j.clim.2021.108765 PB - Elsevier SP - 108765EP - UR - https://hdl.handle.net/10442/18147 N2 - Whether and how an acute immune challenge may affect DNA Damage Response (DDR) is unknown. By studying vaccinations against Influenza and SARS-CoV-2 (mRNA-based) we found acute increases of type-I interferon-inducible gene expression, oxidative stress and DNA damage accumulation in blood mononuclear cells of 9 healthy controls, coupled with effective anti-SARS-CoV-2 neutralizing antibody production in all. Increased DNA damage after SARS-CoV-2 vaccine, partly due to increased oxidative stress, was transient, whereas the inherent DNA repair capacity was found intact. In contrast, in 26 patients with Systemic Lupus Erythematosus, who served as controls in the context of chronic immune activation, we validated increased DNA damage accumulation, increased type-I interferon-inducible gene expression and induction of oxidative stress, however aberrant DDR was associated with deficiencies in nucleotide excision repair pathways. These results indicate that acute immune challenge can indeed activate DDR pathways, whereas, contrary to chronic immune challenge, successful repair of DNA lesions occurs. ER -